Korro Bio (NASDAQ:KRRO – Get Free Report) is one of 977 public companies in the “Pharmaceutical preparations” industry, but how does it contrast to its peers? We will compare Korro Bio to similar companies based on the strength of its institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares Korro […]
TODAY’S GAME PLAN: from the trading desk, this is not research DATA/HEADLINES 10:00ET Factory Orders, Durable Goods Orders, Cap Goods TODAY’S HIGHLIGHTS: The College Football Playoff snubs undefeated Florida State for AlabamaGen Z is expected to overtake baby boomers in the workforce by next year The Israeli military struck around 200 targets in southern
H.C. Wainwright initiated coverage on Korro Bio Inc KRRO, a biotech company developing genetic medicines focused on editing ribonucleic acid (RNA) to treat…
H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused on editing ribonucleic acid (RNA) to treat various diseases.
Korro Bio Appoints Dr Rachel Meyers to Board of Directors tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.